Forasma

Composition :

Eact tablet FORASMA® contains Terbutaline sulfate 2.5 mg

Eact 5 ml (1 measuring spoon) syrup FORASMA® contains Terbutaline sulfate 1.25 mg

 

Pharmacology :

  • Terbutaline Sulfate is a selective amino sympatomimetic stimulant β2 receptor and causes relaxation of the bronchial and uterine muscle
  • Terbutaline Sulfate also accelerates cilia movement and increases sticky mucus transport
  • Effects of therapy usually occur after 50 minutes of oral administration and maximum at 120-180 minutes

 

Indication :

To relieve bronchi spasm in chronic respiratory diseases such as bronchial asthma, chronic bronchitis and emphysema

 

Dosage :

Tablet :

  • Adult: 1-2 tablet, 3 times daily
  • Patients who sensitive to amino sympatomimetic recommended initial dose of 1 tablet, 3 times daily, if bronchodilatation effect is not enough doses can be added
  • Children: 1 tablet, 3 times daily

 

Syrup :

  • Adult: 2-3 measuring spoons (10-15 mL), 3 times daily
  • Children (12-15 years old): 1-2 measuring spoons (5-10 mL), 3 times daily

 

Presentation and Registration Number :

FORASMA® Tablet Box, 5 strips @ 10 tablets; DKL9608006210A1

FORASMA® Syrup Box, Bottle @ 60 ml; DKL9608006337A1

 

ON MEDICAL PRESCRIPTION ONLY

 

Categorised in:

This post was written by admin